| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1572-0241.2007.01547.X |
| P8608 | Fatcat ID | release_cjt6yrcpxnaglo2yvojgss4pq4 |
| P698 | PubMed publication ID | 17900321 |
| P5875 | ResearchGate publication ID | 5945076 |
| P50 | author | Daisy M A E Jonkers | Q90645876 |
| Reinhold W Stockbrugger | Q114455717 | ||
| P2093 | author name string | Ellen E Stobberingh | |
| Linda Mulder | |||
| Catherina J M Koning | |||
| Frans M Rombouts | |||
| P2860 | cites work | Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis | Q24529831 |
| Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea | Q28259833 | ||
| Short-chain fatty acid and organic acid concentrations in feces of healthy human volunteers and their correlations with anaerobe cultural counts during systemic ceftriaxone administration | Q28335968 | ||
| Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children | Q29028534 | ||
| Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea | Q33451610 | ||
| Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content of faeces after ingestion of a rose-hip drink with fermented oats | Q33487773 | ||
| Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. | Q33786301 | ||
| Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study | Q33878836 | ||
| Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. | Q33960898 | ||
| Colonic health: fermentation and short chain fatty acids | Q33995272 | ||
| Monostrain, multistrain and multispecies probiotics--A comparison of functionality and efficacy | Q34353982 | ||
| The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans | Q34486626 | ||
| Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease | Q34517039 | ||
| Antibiotic induced endotoxin release and clinical sepsis: a review | Q34589987 | ||
| Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate | Q35167963 | ||
| Antibiotic-associated diarrhea | Q35462185 | ||
| Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis | Q35596222 | ||
| Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid | Q35597617 | ||
| Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition | Q35621330 | ||
| Clostridium difficile-associated diarrhea in adults | Q35828291 | ||
| Diagnosis and therapy of irritable bowel syndrome. | Q35873847 | ||
| Understanding the effects of diet on bacterial metabolism in the large intestine | Q36797298 | ||
| A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome | Q39396709 | ||
| In situ bacterial metabolism and colon mutagens | Q39747525 | ||
| Antibiotic-induced release of endotoxin. A therapeutic paradox. | Q40449524 | ||
| Clostridium difficile colitis | Q40679117 | ||
| Probiotic bacteria enhance murine and human intestinal epithelial barrier function | Q40783633 | ||
| Immunomodulating effects of antibiotics: literature review | Q41170491 | ||
| Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria | Q41466082 | ||
| Nosocomial acquisition of Clostridium difficile infection | Q41877583 | ||
| Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy | Q43715502 | ||
| Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea | Q45156874 | ||
| Survival of the probiotic, L. plantarum 299v and its effects on the faecal bacterial flora, with and without gastric acid inhibition | Q45259019 | ||
| The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance | Q45262686 | ||
| Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. | Q45980203 | ||
| Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident | Q46550623 | ||
| Mechanisms and management of antibiotic-associated diarrhea | Q50128861 | ||
| The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients | Q50891759 | ||
| Epidemiology, risk factors and treatments for antibiotic-associated diarrhea | Q52533461 | ||
| Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double-blind, placebo-controlled pilot study | Q52563743 | ||
| Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora | Q54232270 | ||
| Diagnosis and epidemiology of Clostridium difficile enterocolitis in Sweden. | Q54464020 | ||
| The influence of the host on expression of intestinal microbial enzyme activities involved in metabolism of foreign compounds. | Q54789445 | ||
| The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy | Q58228933 | ||
| VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis | Q59120549 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibiotic | Q12187 |
| probiotics | Q1816730 | ||
| P304 | page(s) | 178-189 | |
| P577 | publication date | 2007-09-25 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin | |
| P478 | volume | 103 |
| Q57210305 | A Pilot Randomized Controlled Trial to Explore Cognitive and Emotional Effects of Probiotics in Fibromyalgia |
| Q58798841 | A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The Netherlands |
| Q38062305 | Adaptation of bifidobacteria to the gastrointestinal tract and functional consequences |
| Q34326485 | Association of fecal microbial diversity and taxonomy with selected enzymatic functions |
| Q34981520 | Can probiotic yogurt prevent diarrhoea in children on antibiotics? A double-blind, randomised, placebo-controlled study |
| Q34110225 | Changes in Human Fecal Microbiota Due to Chemotherapy Analyzed by TaqMan-PCR, 454 Sequencing and PCR-DGGE Fingerprinting |
| Q34499198 | Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea |
| Q55078100 | Effect of a multispecies probiotic on reducing the incidence of antibiotic-associated diarrhoea in children: a protocol for a randomised controlled trial. |
| Q43349027 | Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial |
| Q35962771 | Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid |
| Q33962888 | Effects of probiotics on acquisition and spread of multiresistant enterococci |
| Q59280914 | Effects on intestinal microbiota of probiotic fermented milk used for prevention of antibiotic-associated diarrhoea |
| Q42369781 | Emerging Trends in "Smart Probiotics": Functional Consideration for the Development of Novel Health and Industrial Applications |
| Q29616812 | Gut Microbiota in Health and Disease |
| Q38044515 | Gut microbiota, immune development and function |
| Q34169953 | Hospital and community ampicillin-resistant Enterococcus faecium are evolutionarily closely linked but have diversified through niche adaptation |
| Q34626824 | Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults |
| Q35044588 | Manipulating the gut microbiota to maintain health and treat disease |
| Q47858003 | Meta‐analysis: probiotics in antibiotic‐associated diarrhoea |
| Q39281119 | Microbiota and probiotics: effects on human health |
| Q34300645 | Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial |
| Q38821454 | Probiotics Reduce the Risk of Antibiotic-Associated Diarrhea in Adults (18-64 Years) but Not the Elderly (>65 Years): A Meta-Analysis. |
| Q24202700 | Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children |
| Q46236620 | Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. |
| Q24186991 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q24235039 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q91644124 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q92876444 | Probiotics in the next-generation sequencing era |
| Q58796769 | Rebuilding the Gut Microbiota Ecosystem |
| Q34178012 | Reliability and Validity of a Modified Bristol Stool Form Scale for Children |
| Q64982190 | Stress matters: Randomized controlled trial on the effect of probiotics on neurocognition. |
| Q91235299 | Study protocol of a double-blind randomised placebo-controlled trial on the effect of a multispecies probiotic on the incidence of antibiotic-associated diarrhoea in persons with spinal cord injury |
| Q43456424 | The effects of the multispecies probiotic mixture Ecologic®Barrier on migraine: results of an open-label pilot study |
| Q35494817 | The potential role of probiotics in the management of childhood autism spectrum disorders. |
| Q37401586 | The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrhea |
| Q37767505 | Therapeutical use of probiotic formulations in clinical practice. |
Search more.